News out and volume picking up big time---------------------------------------------------------------------------
LA JOLLA, Calif., May 12 /PRNewswire/ -- La Jolla Diagnostics, Inc. (OTC Bulletin Board: LAJD), announced today that it plans to develop products for the symptomatic relief of allergies.
These products will be prepared using water processed by a recently patented technology* to form ClusterWater(TM). While remaining chemically identical with unprocessed water, ClusterWater forms polywater complexes which enhance the effectiveness of biological solutions. *U.S. Patent 5711950
ClusterWater is also used in the formulation of the following products for which La Jolla Diagnostics is beginning to receive bulk orders:
Feverfew Nasal Mist(TM), a patent pending moisturizing nasal spray,
MigraSpray(TM) a saline solution containing the herb feverfew (commonly used as a treatment for migraine headaches) and designed to be sprayed under the tongue,
Living Water Eye Lotion(TM), a saline solution which cleanses and soothes the eye without interfering with natural functions, and
OptoPet(TM) Eye Wash for cleansing the eyes of dogs and cats and removing mucous which causes fur stains beneath the eyes, a major problem in certain breeds.
La Jolla Diagnostics is a company engaged in the development and marketing of diagnostic tests and consumer health care products, and the licensing of drug delivery systems.
SOURCE La Jolla Diagnostics, Inc.
/CONTACT: Clenton Alexander for La Jolla Diagnostics, Inc., 800-572-7177/
(LAJD)
|
